FDA
-
-
-
-
-
-
-
Abivax prices upsized $800M ADS offering at $125 per share
-
-
-
-
-
-
-
After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
-
-
-
-
-
-
-
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
-
-
-
-
-
-
-
Abivax presents ulcerative colitis drug data at gastroenterology meeting
-
-
-
-
-
-
-
Abivax launches $400 million public offering of American depositary shares
-
-
-
-
-
-
-
Abivax (ABVX) Appoints Dominik Höchli to its Board
-
-
-
-
-
-
-
Abivax (ABVX) Announces $150M ATM Program
-
334,256 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


